Molecular profiling and safety study of operable lung cancer patients treated with Alimta [pemetrexed] combined with cisplatin as neoadjuvant chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2011
At a glance
- Drugs Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.